Gallium-68 in Medical Imaging

Author(s): Lucia Martiniova, Louis De Palatis, Elba Etchebehere, Gregory Ravizzini

Journal Name: Current Radiopharmaceuticals

Volume 9 , Issue 3 , 2016

Become EABM
Become Reviewer

Graphical Abstract:


Over the past several years, Positron Emission Tomography (PET) imaging agents labeled with 68Gallium (68Ga) have undergone a significant increase in clinical utilization. 68Ga is conveniently produced from a germanium-68/gallium-68 (68Ge/68Ga) generator. Because of the compact size and ease of use of the generator, 68Ga labeled compounds may be more cost-effective than PET radioisotopes that are cyclotron-produced. The convenient half-life of 68Ga (T1/2=68 min) provides sufficient radioactivity for various PET imaging applications, while delivering acceptable radiation doses to patients. This chapter summarizes the emerging clinical utilization of 68Ga-based radiotracers in medical imaging.

Keywords: 68Gallium, generator, neuroendocrine tumors, positron emission tomography, somatostatin receptor scintigraphy, PSMA.

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 11 December, 2016
Page: [187 - 207]
Pages: 21
DOI: 10.2174/1874471009666161028150654

Article Metrics

PDF: 97
HTML: 19